Clinical Trial: Phase I Study of Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming in Advanced Solid Tumors

U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07563972) titled 'Phase I Study of Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming in Advanced Solid Tumors' on April 26.

Brief Summary: The goal of this phase I clinical trial is to evaluate the safety and tolerability of intratumoral injection of mechanically reprogrammed macrophage-derived exosomes (MRMEs) in adults aged 18-65 years with advanced solid tumors who have failed, are ineligible for, or are intolerant of standard therapies.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors Neoplasm

Intervention: BIOLOGICAL: Mechanobiologically Reprogrammed Macrophage-Derived Exosomes (1x10...